Abaxis, Inc. (ABAX) Pops to Record High at $83.34 on May, 17

May 16, 2018 - By Sonya McDaniel

Abaxis, Inc. (NASDAQ:ABAX) Corporate Logo

Big Money Sentiment decreased to 1.27 in 2017 Q4. It has change of 0.05, from 2017Q3’s 1.32. The ratio turned negative due to Abaxis, Inc. positioning: 12 sold and 40 reduced. 25 funds acquired positions and 41 increased positions. Investors holded 21.83 million in 2017Q3 but now own 21.66 million shares or 0.81% less.
Ls Invest Advsr Limited Company owns 717 shs or 0% of their US capital. Legal General Public owns 0% invested in Abaxis, Inc. (NASDAQ:ABAX) for 44,733 shs. Renaissance Technologies Ltd holds 162,971 shs or 0.01% of its capital. Parkside Bank & Trust & Trust invested in 12 shs or 0% of the stock. Vanguard Incorporated reported 2.08M shs stake. Geode Cap Limited Co invested 0% of its capital in Abaxis, Inc. (NASDAQ:ABAX). Piedmont Invest Advisors Ltd Company holds 4,665 shs. C M Bidwell Associates reported 102 shs or 0% of all its holdings. Wells Fargo Mn owns 635,213 shs or 0.01% of their US capital. Moreover, Rockefeller Fin Ser has 0.15% invested in Abaxis, Inc. (NASDAQ:ABAX). California Pub Employees Retirement owns 63,723 shs for 0% of their capital. Louisiana State Employees Retirement Systems reported 9,800 shs. Copeland Cap Limited Liability Co reported 328,536 shs. Mason Street Limited Liability Corp owns 0.01% invested in Abaxis, Inc. (NASDAQ:ABAX) for 5,903 shs. Barclays Public Ltd Co owns 3,793 shs for 0% of their capital.

Abaxis, Inc. had 10 sales and 0 insider buys since January 30, 2018. This’s net activity of $2.85 million. Shares for $333,460 were sold by EVENHUIS HENK. ARON KENNETH sold $98,266 worth of Abaxis, Inc. (NASDAQ:ABAX) or 1,412 shs on Tuesday, March 6. The insider Henkel Achim sold $304,953. The insider SINGH PRITHIPAL sold $149,255. CASEY MICHAEL D also sold $355,327 worth of Abaxis, Inc. (NASDAQ:ABAX) on Thursday, March 8. Shares for $122,652 were sold by TOCKMAN CRAIG on Wednesday, January 31.

Abaxis, Inc. (NASDAQ:ABAX) touched all time high on May, 17 with $88.34 target or 6.00 % above the last $83.34 share price. The all time high was reported by Barchart.com. The company has $1.89 billion MC. At our $88.34 target, the company worth will be $113.52 million more.

ABAX reached $83.34 during the last trading session after $11.59 change.Abaxis, Inc. is uptrending after having risen 44.47% since May 17, 2017. ABAX has 4.19M volume or 2804.89% up from normal. The stock outperformed the S&P 500 by 32.92%.

Abaxis, Inc. (NASDAQ:ABAX)’s quarterly earnings will be announced on July, 26., Zacks reports. Analysts have expectation on stock’s earnings per share of $0.35. That’s up 25.00 % from last year’s $0.28 earnings per share. If the current earnings per share of $0.35 is accurate, ABAX’s profit could hit $7.95M. Analysts at Wall Street see Abaxis, Inc.’s -16.67 % negative EPS growth compared to $0.42 earnings per share for last quarter.

Abaxis, Inc. (NASDAQ:ABAX) Ratings Coverage

A total of 7 analysts rate Abaxis (NASDAQ:ABAX) as follows: 1 “Buy”, 5 “Hold” and 1 “Sell”. Тherefore 14% are bullish. The firm has $90.0 highest and $48 lowest target. The avg target $65 is -22.01% below the last ($83.34) price. (NASDAQ:ABAX) has 11 ratings reports on May 17, 2018 according to StockzIntelligence. In Monday, January 29 report Canaccord Genuity maintained the stock with “Hold” rating. The stock rating was maintained by Northcoast with “Buy” on Monday, January 29. On Friday, January 26 the firm has “Hold” rating given by Stephens. On Friday, April 27 Stifel Nicolaus maintained Abaxis, Inc. (NASDAQ:ABAX) rating. Stifel Nicolaus has “Hold” rating and $62 target. On Tuesday, January 9 Northcoast maintained the shares of ABAX in report with “Buy” rating. On Tuesday, January 16 Canaccord Genuity maintained the shares of ABAX in report with “Hold” rating. On Thursday, February 8 the rating was maintained by Bank of America with “Underperform”. On Thursday, January 25 the rating was maintained by Stifel Nicolaus with “Hold”. On Wednesday, May 16 the company was downgraded by Sidoti. On Tuesday, January 9 the company was upgraded by Raymond James.

For more Abaxis, Inc. (NASDAQ:ABAX) news brought out briefly go to: Businesswire.com, Benzinga.com, Benzinga.com, 247Wallst.com or Fool.com. The titles are as follows: “Bragar Eagel & Squire, PC is Investigating the Board of Directors of Abaxis, Inc. (ABAX) on Behalf of Stockholders and …” brought out on May 16, 2018, “26 Stocks Moving In Wednesday’s Pre-Market Session” on May 16, 2018, “A Preview Of Abaxis Q4 Earnings” with a publish date: April 26, 2018, “Are Abaxis Shareholders Getting Enough in the Buyout?” and the last “Why Under Armour, Boot Barn Holdings, and Abaxis Jumped Today” with publication date: May 16, 2018.

Abaxis, Inc. develops, manufactures, markets, and sells portable blood analysis systems for use in human or veterinary patient care settings to provide rapid blood constituent measurements for clinicians worldwide.The firm is valued at $1.89 billion. It operates in two divisions, Medical Market and Veterinary Market.77.17 is the P/E ratio. The firm offers Piccolo chemistry analyzers with rapid blood constituent measurements for use in human patient care; and Piccolo profiles that are single-use medical reagents.

Abaxis, Inc. (NASDAQ:ABAX) Institutional Investors Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.